NEW YORK, Feb. 17 (GenomeWeb News) - Qiagen today reported a 21 percent revenue increase, along with a rise in net income and R&D spending, for the fourth quarter ended Dec. 31, 2003.

The company posted revenues of $95.1 million for the fourth quarter of 2003, up from $78.4 million in the year-ago period.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.